🏛️ Verified NIH Record • Updated 2026-08-03
Abbott Medical - VERITAS Study (NCT06707688)
🔵 Active, Not Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: Abbott Medical Devices
🩺 Plain-English Summary (8th-Grade Level)
The primary objective of this study is to evaluate the safety and effectiveness of Abbott's Amulet™ 2 Left Atrial Appendage (LAA) occluder device (Amulet 2 device) in patients who have non-valvular atrial fibrillation and who are at increased risk for stroke and systemic embolism and have appropriate rationale to seek a non-pharmacologic alternative to oral anticoagulation.
Who can join: Review the eligibility criteria below.
Location: Arizona Arrhythmia Research Group — Phoenix, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (35 Sites)
Showing the first 25 of 35 sites.
- Arizona Arrhythmia Research Group — Phoenix, Arizona
- Arrhythmia Research Group — Jonesboro, Arkansas
- Baptist Medical Center — Jacksonville, Florida
- AdventHealth Orlando — Orlando, Florida
- Northside Hospital — Atlanta, Georgia
- Kansas City Cardiac Arrhythmia Research Foundation — Overland Park, Kansas
- Henry Ford Providence Southfield Hospital — Southfield, Michigan
- Mayo Clinic — Rochester, Minnesota
- CHI Health Creighton University Medical Center-Bergan Mercy — Omaha, Nebraska
- NYU Langone Health — New York, New York
- Mount Sinai Hospital — New York, New York
- Roper Hospital — Charleston, South Carolina
- Trident Medical Center — Charleston, South Carolina
- Vanderbilt Heart & Vascular Institute — Nashville, Tennessee
- Texas Cardiac Arrhythmia — Austin, Texas
- Baylor Scott & White All Saints Medical Center — Fort Worth, Texas
- Vital Heart and Vein — Humble, Texas
- Baylor Scott & White - The Heart Hospital Plano — Plano, Texas
- Heart Rhythm Associates — Shenandoah, Texas
- Hôpital Civil Marie Curie — Lodelinsart,
- University of Ottawa Heart Institute — Ottawa, Ontario
- Institut de Cardiologie de Montreal (Montreal Heart Inst.) — Montreal, Quebec
- Aarhus Universitetshospital — Aarhus,
- Rigshospitalet — Copenhagen,
- CHU Gabriel Montpied — Clermont-Ferrand, Auvergn
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Atrial Fibrillation (AF)
- Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring — La Jolla, California
- Phase-Aligned Atrial Fibrillation Mapping — Cleveland, Ohio
- Left Atrial Pressure-Guided Heart Failure Optimization During Atrial Fibrillation Ablation (LAP AF-HF) — Milwaukee, Wisconsin
- AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment — Los Angeles, California
- P-wave Duration and Local Potential as Predictors of AF Recurrence Following Pulmonary Vein Isolation — Paramus, New Jersey
- Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation — Huntsville, Alabama
Explore by condition: All Atrial Fibrillation (AF) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.